Want to join the conversation?
Biotechnology company $ACOR said that Enrique Carrazana, Chief Medical Officer, is retiring from the company effective Jan. 4, 2016 and Burkhard Blank will assume the responsibilities as CMO on an interim basis. Prior to this appointment, Blank served as a consultant to the Company's commercial & business development departments.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.